230: IVIG for refractory HIT, differences in QTc risk among quinolones, and a resource for searching FDA reports of adverse reactions to medications

Show notes at pharmacyjoe.com/episode230.

In this episode I’ll:
1. Discuss an article about using IVIG for refractory HIT.
2. Answer the drug information question “Do some quinolones have lower QTc prolongation risk than others?”
3. Share a resource for searching FDA reports of adverse reactions to medications.